Patent · US Active

Pharmaceutical semi-solid composition of isotretinoin

US8952064B2 · kind B2 · utility

4Cited by

12References

12Claims

0Family size

Assignee

GALEPHAR PHARMACEUTICAL RESEARCH, INC. · US

Inventors

Francis Vanderbist · Sint-Genesius-Rode, BE
Cecile Servais · Malonne, BE
Philippe Baudier · Waterloo, BE

Key dates

Filing date	Jun 18, 2012
Grant date	Feb 10, 2015
Priority date	—
Expiry date	Jun 18, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/1075
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.